Skip to main content
. 2019 Sep 5;59(4):1717–1727. doi: 10.1007/s00394-019-02026-0

Table 3.

Associations of artificially and sugar-sweetened beverage consumption with continuous BCF and insulin sensitivity measures (standardized betas and 95% confidence intervals)

Model Non-consumers (ref) Moderate consumers Daily consumers
Β β (95% CI) β (95% CI)
Artificially sweetened soft drink
 N 1187 887 166
 β-Cell glucose sensitivity Crude 0 − 0.08 (− 0.12, − 0.04) − 0.08 (− 0.12, − 0.03)
Fully adjusted 0 − 0.06 (− 0.11, − 0.02) − 0.05 (− 0.09, 0.00)
 β-Cell potentiation factor Crude 0 − 0.04 (− 0.08, 0.01) − 0.06 (− 0.10, − 0.01)
Fully adjusted 0 − 0.02 (− 0.06, 0.03) − 0.02 (− 0.06, 0.02)
 C-peptidogenic index Crude 0 − 0.02 (− 0.06, 0.02) − 0.01 (− 0.06, 0.03)
Fully adjusted 0 − 0.02 (− 0.06, 0.03) − 0.01 (− 0.05, 0.04)
 Overall insulin secretion Crude 0 − 0.07 (− 0.11, − 0.03) − 0.07 (− 0.11, − 0.03)
Fully adjusted 0 − 0.06 (− 0.10, − 0.02) − 0.05 (− 0.09, − 0.01)
 Matsuda indexa Crude 0 − 0.06 (− 0.10, − 0.02) − 0.09 (− 0.13, − 0.05)
Fully adjusted 0 − 0.01 (− 0.05, 0.03) − 0.01 (− 0.05, 0.03)
Sugar-sweetened soft drink
 N 825 1299 116
 β-Cell glucose sensitivity Crude 0 0.03 (− 0.02, 0.07) − 0.01 (− 0.06, 0.03)
Fully adjusted 0 0.00 (− 0.04, 0.05) − 0.01 (− 0.06, 0.03)
 β-Cell potentiation factor Crude 0 0.02 (− 0.02, 0.06) − 0.03 (− 0.07, 0.02)
Fully adjusted 0 0.01 (− 0.04, 0.05) − 0.02 (− 0.07, 0.02)
 C-peptidogenic index Crude 0 0.02 (− 0.03, 0.06) − 0.02 (− 0.06, 0.03)
Fully adjusted 0 0.01 (− 0.03, 0.06) − 0.02 (− 0.06, 0.03)
 Overall insulin secretion Crude 0 0.03 (− 0.02, 0.07) − 0.01 (− 0.05, 0.04)
Fully adjusted 0 0.01 (− 0.05, 0.04) − 0.01 (− 0.05, 0.03)
Matsuda indexa Crude 0 0.00 (− 0.04, 0.04) − 0.04 (− 0.08, 0.01)
Fully adjusted 0 0.00 (− 0.04, 0.03) − 0.01 (− 0.05, 0.03)
Juice
 N 274 1851 115
 β-Cell glucose sensitivity Crude 0 0.06 (0.01, 0.11) 0.02 (− 0.03, 0.07)
Fully adjusted 0 0.03 (− 0.02, 0.08) 0.00 (− 0.05, 0.05)
 β-Cell potentiation factor Crude 0 0.01 (− 0.04, 0.05) 0.02 (− 0.02, 0.07)
Fully adjusted 0 − 0.02 (− 0.06, 0.03) 0.02 (− 0.03, 0.06)
 C-peptidogenic index Crude 0 0.01 (− 0.04, 0.06) 0.00 (− 0.05, 0.05)
Fully adjusted 0 0.01 (− 0.04, 0.06) 0.00 (− 0.05, 0.05)
 Overall insulin secretion Crude 0 0.05 (0.1, 0.10) 0.02 (− 0.03, 0.06)
Fully adjusted 0 0.02 (− 0.02, 0.07) − 0.01 (− 0.06, 0.04)
 Matsuda indexa Crude 0 0.06 (0.02, 0.11) 0.01 (− 0.03, 0.06)
Fully adjusted 0 0.03 (− 0.02, 0.07) 0.01 (− 0.04, 0.05)
Total sugar-sweetened beverage
 N 145 1689 406
 β-Cell glucose sensitivity Crude 0 0.08 (0.01, 0.16) 0.05 (− 0.03, 0.12)
Fully adjusted 0 0.05 (− 0.02, 0.12) 0.02 (− 0.05, 0.09)
 β-Cell potentiation factor Crude 0 0.04 (− 0.03, 0.11) 0.01 (− 0.06, 0.09)
Fully adjusted 0 0.02 (− 0.06, 0.09) 0.01 (− 0.06, 0.08)
 C-peptidogenic index Crude 0 0.03 (− 0.04, 0.11) 0.01 (− 0.07, 0.08)
Fully adjusted 0 0.03 (− 0.05, 0.10) 0.01 (− 0.07, 0.09)
 Overall insulin secretion Crude 0 0.08 (0.01, 0.15) 0.03 (− 0.04, 0.10)
Fully adjusted 0 0.04 (− 0.03, 0.11) − 0.01 (− 0.08, 0.07)
 Matsuda indexa Crude 0 0.08 (0.01, 0.15) 0.00 (− 0.07, 0.08)
Fully adjusted 0 0.04 (− 0.03, 0.10) 0.01 (− 0.05, 0.08)

Positive values indicate a better BCF or insulin sensitivity, and negative values indicate a lower BCF or insulin sensitivity

Crude model: model adjusted for sex, age, and insulin sensitivity

Fully adjusted model: model adjusted for sex, age, insulin sensitivity, education, blood pressure expressed in MAP, lipid-modifying medication, antihypertensive medication, moderate-to-vigorous physical activity, high-density cholesterol, low-density cholesterol, triglycerides, intake of dietary fibre, trans fat, red meat and fruit intake, mutual adjustment for the other beverage category, total energy intake, and body mass index

aMatsuda index is not adjusted for insulin sensitivity